Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600529.SS

BUYFLAG

Shandong Pharmaceutical Glass Co.Ltd · Consumer Cyclical · China · $1.9B · Avg Vol: $33M/d

69
StockRank
Q
66
V
43
M
48
P/E (TTM)
18.2x
ROE
8.0%
D/E
0.0x
Dividend %
2.5%
AI CONVICTION THESIS

Shandong Pharmaceutical Glass is a dominant manufacturer of pharmaceutical glass packaging in China. It possesses a strong regulatory moat and high switching costs, acting as a critical supplier to the domestic pharma and CDMO sectors. However, domestic pricing controls and geopolitical trade barriers limit its immediate global upside.

COMPANY DESCRIPTION

Shandong Pharmaceutical Glass Co., Ltd. manufactures pharmaceutical glass packaging, including molded vials, ampoules, and cosmetic glass bottles. The company holds a dominant market share in China's molded pharmaceutical glass vial segment, with high switching costs for drug manufacturers. It is a highly specialized, low-cost, high-volume packaging leader with a global export footprint.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue619M705M725M661M2.2%
EPS0.150.170.210.150.3%
Shares664M664M664M664M0.0%
Debt768,813269,809315M6M93.2%
Equity1.0B1.1B1.2B1.2B6.0%
Op CF37M155M172M85M31.7%
Inv CF-220M-110M-165M-22M
Fin CF247M-28M-69M-56M
Loading...
PRICE (1M)+1.6%
2.562.652.742.822.91May 8May 29Jun 18
SMA 50SMA 200
Close
$2.74
RSI (14)
42.7
52W High
$3.46
From 52W High
0.8%

SCORE BREAKDOWN

Quality
66
ROIC
9.8%58.8
ROE
8.0%50.6
GP/Assets
14.1%28.0
Op. Margin
21.2%92.0
FCF/Assets
3.0%48.0
Piotroski
75.1
Int. Cover
50.0x91.6
D/E Ratio
0.01x97.4
Current Ratio
3.79x90.0
Value
43
P/E (TTM)
18.2x47.3
EV/EBITDA
7.6x60.8
P/FCF
287.2x19.0
P/B
1.4x50.9
P/S
2.7x19.2
Div Yield
2.5%50.4
Momentum
48
52W High %
79%55.9
RS 6M
-16%61.8
SMA 50/200
0.93x33.7
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+40%47.3
Q Growth
-10%33.4

FUNDAMENTALS

Market Cap
$1.9B
P/E (Forward)
13.0x
Gross Margin
31.1%

SECTOR PEERS

Closest peers in Consumer Cyclical, ranked by industry match, size, and score similarity. Cross-listings of 600529.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600529.SSShandong Pharmaceutical Glass Co.Ltd(you)$1.9B69BUY
600210.SSShanghai Zijiang Enterprise Group Co., Ltd.$1.5B64HOLD
002014.SZHuangshan Novel Co.,Ltd$960M70BUY
002803.SZXiamen Jihong Co., Ltd$1.5B85STRONG BUY
002701.SZORG Technology Co., Ltd.$1.9B43HOLD
002752.SZSunrise Group Company Limited$957M55HOLD
002585.SZJiangsu Shuangxing Color Plastic New Materials Co., Ltd.$1.7B41HOLD
301004.SZZhejiang Cayi Vacuum Container Co., Ltd.$829M55HOLD
002191.SZShenzhen Jinjia Group Co.,Ltd.$790M52HOLD
002831.SZShenZhen YUTO Packaging Technology Co., Ltd.$5.2B55HOLD

Peer medians: ROE 7.0% · P/E 24.0x · Gross margin 21.9%

Shandong Pharmaceutical Glass Co.Ltd (600529.SS) — Stock Score Summary

Shandong Pharmaceutical Glass Co.Ltd (600529.SS) has a MoatMap StockRank of 69/100 based on Quality (66/100), Value (43/100), and Momentum (48/100) factor scores. The current signal is BUY. Shandong Pharmaceutical Glass is a dominant manufacturer of pharmaceutical glass packaging in China. It possesses a strong regulatory moat and high switching costs, acting as a critical supplier to the domestic pharma and CDMO sectors. However, domestic pricing controls and geopolitical trade barriers limit its immediate global upside.

Shandong Pharmaceutical Glass Co., Ltd. manufactures pharmaceutical glass packaging, including molded vials, ampoules, and cosmetic glass bottles. The company holds a dominant market share in China's molded pharmaceutical glass vial segment, with high switching costs for drug manufacturers. It is a highly specialized, low-cost, high-volume packaging leader with a global export footprint.

Key Financial Metrics

Price$2.74
Market Cap$1.9B
P/E (TTM)18.24
P/E (Forward)13.03
Price/Book1.45
Return on Equity8.0%
Return on Invested Capital9.8%
Debt/Equity0.51
Gross Margin31.1%
Operating Margin21.2%
Revenue Growth4.1%
Dividend Yield2.5%
Free Cash Flow$7M

Shandong Pharmaceutical Glass Co.Ltd operates in the Packaging & Containers industry, part of the Consumer Cyclical sector (China).

Frequently Asked Questions

What is Shandong Pharmaceutical Glass Co.Ltd’s (600529.SS) StockRank?
MoatMap’s StockRank for Shandong Pharmaceutical Glass Co.Ltd (600529.SS) is 69/100, with a Buy signal. It is a composite of Quality (66), Value (43), and Momentum (48) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shandong Pharmaceutical Glass Co.Ltd have an economic moat?
Shandong Pharmaceutical Glass Co.Ltd (600529.SS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Pharmaceutical Glass Co.Ltd a buy, hold, or sell?
MoatMap’s current signal for Shandong Pharmaceutical Glass Co.Ltd (600529.SS) is Buy, based on a StockRank of 69/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Pharmaceutical Glass Co.Ltd in?
Shandong Pharmaceutical Glass Co.Ltd (600529.SS) operates in the Consumer Cyclical sector, specifically the Packaging & Containers industry (China).